|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.335 USD | -2.71% |
|
-1.48% | +29.17% |
| 14/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.71% | -1.48% | -1.06% | +9.67% | +29.17% | +55.00% | +40.06% | +43.52% | -64.13% | 193M | |
| +2.05% | +3.93% | -0.67% | +39.78% | +13.67% | +51.17% | +166.45% | +395.57% | +1,373.10% | 1,068B | |
| +0.58% | +7.02% | +3.75% | +17.75% | +29.60% | +61.36% | +53.72% | +55.78% | +115.50% | 641B | |
| +3.36% | +3.69% | +4.42% | +34.33% | +16.22% | +40.86% | +76.03% | +124.00% | +310.30% | 454B | |
| +2.17% | +10.22% | +8.59% | +14.57% | +12.10% | +41.17% | +36.56% | +5.84% | +49.86% | 351B | |
| +1.46% | +3.87% | +3.33% | +13.67% | +18.98% | +39.70% | +44.49% | +55.28% | +62.39% | 299B | |
| +0.40% | +3.59% | -9.50% | -6.91% | -6.16% | +19.93% | +17.02% | +56.54% | +157.41% | 266B | |
| +2.73% | +3.50% | +6.51% | +26.49% | +3.12% | -25.66% | -36.53% | +16.70% | +77.51% | 220B | |
| +4.08% | +6.90% | +8.58% | +15.29% | +19.61% | +29.94% | +65.63% | +60.29% | +128.57% | 203B | |
| +2.59% | +2.72% | +5.94% | +3.54% | +9.04% | +18.40% | +74.12% | +91.02% | +64.73% | 162B | |
| +2.09% | +0.98% | +3.34% | -4.89% | +1.14% | +3.60% | -30.18% | -42.04% | -31.32% | 141B | |
| +1.61% | +4.32% | +8.54% | +9.10% | +17.83% | +33.78% | +3.50% | -7.52% | -14.87% | 128B | |
| +1.66% | +0.93% | -2.64% | +13.09% | +7.30% | +5.56% | +37.40% | +140.54% | +405.62% | 122B | |
| +2.04% | +3.43% | +5.14% | +0.62% | -4.04% | -7.16% | -16.41% | -9.37% | +4.05% | 106B | |
| +3.47% | +7.18% | +2.50% | +0.05% | +11.21% | +45.14% | +46.71% | +15.81% | -4.49% | 104B | |
| +2.21% | -4.45% | -5.85% | -5.99% | -15.09% | -4.66% | +70.75% | +68.25% | +434.27% | 68.84B | |
| -0.43% | +4.82% | +12.92% | +10.08% | +18.80% | +32.75% | +30.52% | +55.37% | +26.30% | 56.28B | |
| -0.42% | -1.24% | +2.17% | +28.43% | +27.07% | +62.42% | -10.25% | -6.91% | -50.13% | 52.78B | |
| -0.58% | -4.10% | +9.49% | -3.77% | -10.54% | -5.51% | +10.77% | -2.22% | +232.99% | 52.23B | |
| +2.89% | +3.34% | +9.33% | +8.58% | +1.63% | +4.64% | +13.03% | - | - | 43.39B | |
| Average | +1.65% | +1.23% | +3.74% | +11.17% | +10.03% | +25.12% | +34.67% | +58.76% | +172.51% | 226.86B | |
| Weighted average by Cap. | +2.00% | +2.35% | +2.80% | +19.89% | +13.31% | +35.64% | +67.38% | +132.83% | +422.06% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
